Lana Medical Co.
Lana Medical Co. (9587.SR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
9587.sr · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Lana Medical Co. (9587.SR) measures how much investors pay for each dollar of the company's trailing earnings. 9587.SR's current PE ratio of 55.88x is calculated by dividing its stock price of $2.79 by its TTM earnings per share of $0.05. +76.2% elevated vs 5Y avg 31.7x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 7 fiscal years · Front-end computedMinQ1 · 25%30.0x
MedianQ3 · 75%48.8x
Max
At 55.88x, 9587.SR's current P/E is higher than in 100% of its annual fiscal year readings over the past 7 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Lana Medical Co.You 9587.SR | $151M | 55.88x | +118.7% | $0.05 |
 Arabian International Healthcare Holding Company 9530.SR | $420M | 18.71x | -26.8% | $1.20 |
 Naba Alsaha Medical Services Company 9546.SR | $480M | 18.70x | -26.8% | $1.31 |
 Al-Razi Medical Co. 9572.SR | $44M | 56.50x | +121.1% | $0.54 |
 Professional Medical Expertise Co. 9574.SR | $300M | 8.14x | -68.1% | $11.92 |
 Almujtama Alraida Medical Co. 9592.SR | $234M | 33.75x | +32.1% | $0.88 |
 Al-Modawat Specialized Medical Co. 9594.SR | $129M | 17.52x | -31.4% | $0.27 |
Industry Average 6 peers with valid PE | — | 25.55x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 48.80x | $0.05 | +62.7% | |
2024-12-31 FY2024 | 30.00x | $0.15 | -38.1% | |
2023-12-31 FY2023 | 48.50x | $0.07 | +196.0% | |
2022-12-31 FY2022 | 16.38x | $0.18 | +9.8% | |
2021-12-31 FY2021 | 14.93x | $0.20 | -30.5% | |
2020-12-31 FY2020 | 21.46x | $0.14 | -46.8% | |
2019-12-31 FY2019 | 40.36x | $0.07 | — | |
2018-12-31 FY2018 | — | $-0.06 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Lana Medical Co. (9587.SR) measures how much investors pay for each dollar of the company's trailing earnings. 9587.SR's current PE ratio of 55.88x is calculated by dividing its stock price of $2.79 by its TTM earnings per share of $0.05.
Frequently asked questions
9587.SR pe ratio · 6 questions9587.SR's current PE ratio is 55.88x as of 2026-06-15, based on a stock price of $2.79 and TTM EPS of $0.05. Data sourced from Financial Modeling Prep via 9587.SR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Lana Medical Co. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15